Clomiphene Citrate Resistant Polycystic Ovary Syndrome Clinical Trial
Official title:
Evaluation of the Clinical Outcome of Vitamin E as Adjuvant Therapy in Patients With Clomiphene Citrate Resistant Polycystic Ovary Syndrome
This study evaluate the addition of Vit E to clomiphene citrate in the treatment of poly cystic ovary.Half the patients will receive both Vit E and clomiphene citrate the other half will receive clomiphene citrate only.
Clomiphene and vit E each used in treatment of pco but they do so by different mechanisms.
Clomifene is in the selective estrogen receptor modulator (SERM) family of medication. It
works by causing the release of gonadotropin-releasing hormone by the hypothalamus, and
subsequently gonadotropin from the anterior pituitary.
Vit E is used in treatment of pco due its anti-oxidant effect.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02775734 -
NAC in CC Resistant PCOS After LOD
|
Phase 2/Phase 3 |